The Leptospirosis is Expected to be Flourished by Increasing Disease Prevalence
![]() |
Leptospirosis Market |
Leptospirosis,
also known as Weil's disease or swineherd's disease, is a bacterial infection
caused by Leptospira interrogans that can cause kidney damage, meningitis, and
liver failure in severe cases. The bacteria is mainly spread through contact
with urine of infected animals like rodents, cattle, pigs, and dogs. Common
symptoms include fever, headache, chills, muscle pains, and vomiting.
Leptospirosis is treated with antibiotics such as penicillin or doxycycline.
With increasing exposure to rats and other animals along with poor sanitation
in many regions, the prevalence of this bacterial infection is growing
significantly.
The
global leptospirosis Market is estimated to be valued at US$ 496.8 Mn in 2023
and is expected to exhibit a CAGR of 4.3% over the forecast period 2023 to
2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Increasing disease prevalence: As per estimates by WHO, there are over 1
million cases of leptospirosis occurring annually worldwide, making it one of
the most widespread zoonotic diseases. Warm and humid climates especially in
developing countries along with factors like flooding which enables rats and
contaminated waters to come in contact with humans, make leptospirosis a
significant burden. The rising infection incidence is expected to drive greater
demand for diagnostic tests and antibiotic treatment drugs for leptospirosis
over the forecast period.
Growing access to diagnostics: Previously, diagnosing leptospirosis was
challenging due to limitations of conventional methods. However, new advanced
diagnostic kits that can confirm presence of leptospira antibodies or DNA in
blood samples with high accuracy and faster turnaround times have been
introduced. This has enabled diagnosing leptospirosis even in primary health
centers. Improved access to reliable diagnostics is expected to support market
gains.
Segment Analysis
The global leptospirosis market is dominated by the diagnostics segment which
holds around 60% market share. Rising instances of the disease and increasing
awareness about early diagnosis is driving the diagnostics segment. Optimum
diagnostics allow for timely treatment which improves disease outcomes.
PEST Analysis
Political: Governments around the world are increasing focus on public health
initiatives to combat infectious diseases like leptospirosis. Support in the
form of funding for R&D and awareness programs will positively influence
the market.
Economic: Growth in the healthcare sector coupled with rising healthcare
expenditures is fueling the leptospirosis market. The development of affordable
diagnostics and therapeutics will enhance access and drive market revenues.
Social: Increasing awareness about leptospirosis symptoms and prevention
through online health sources and social media campaigns is boosting the market
growth. Non-governmental organizations are also contributing to awareness
creation.
Technological: Rapid advancements in molecular diagnostic techniques have
improved disease detection capabilities. Platforms like microarrays and PCR
allow for early-stage diagnosis which aids effective treatment. Development of
recombinant vaccines is also underway.
Key Takeaways
The Global
Leptospirosis Market Demand is expected to witness high growth over the
forecast period. The global Leptospirosis Market is estimated to be valued at
US$ 496.8 Mn in 2023 and is expected to exhibit a CAGR of 4.3% over the
forecast period 2023 to 2030.
Asia
Pacific currently dominates the market and is predicted to maintain its lead
position through 2030. This can be attributed to the increasing disease
incidence and expanding healthcare infrastructure in countries like India,
China, and Indonesia. Countries in Latin America and Africa will also exhibit
notable growth owing to warm climates that promote leptospirosis transmission.
India reports the maximum leptospirosis cases globally accounting for nearly
60% of the world's cases. This has resulted in India emerging as a high growth
market. Countries like China, South Korea and Japan are also contributing to
regional growth.
Key players
Key players operating in the leptospirosis market are Cobham (U.K.), Harris
Corporation (U.S.), AVIC (China), Raytheon (U.S.), Moog (U.S.), Ultra
Electronics (U.K.), Circor Aerospace & Defense (U.S.), Systima Technologies
(U.S.), Marotta Controls (U.S.), and AEREA S.p.A (Italy).
For more details on the report, Read- https://www.pressreleasebulletin.com/leptospirosis-diagnostics-market-size-and-share/
Comments
Post a Comment